Previous radiotherapy negatively influences quality of life during 4 years of follow-up in patients cured from acromegaly

Clinical Endocrinology

Volumn 69, Issue 1, 2008, Pages 123-128

  Van Der Klaauw, Agatha A ^a   Biermasz, Nienke R ^a   Hoftijzer, Hendrieke C ^a   Pereira, Alberto M ^a   Romijn, Johannes A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACROMEGALY; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FATIGUE; FEMALE; FOLLOW UP; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIDIMENSIONAL FATIGUE INDEX; NOTTINGHAM HEALTH PROFILE; PAIN; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; QUESTIONNAIRE; RADIOTHERAPY; SCORING SYSTEM; SHORT FORM 36; SOCIAL INTERACTION; SOCIAL ISOLATION;

ACROMEGALY; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANXIETY; COHORT STUDIES; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOPITUITARISM; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY; SEX FACTORS;

EID: 45349084095     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.03169.x     Document Type: Article

References (27)

1. Wright, A.D., Hill, D.M., Lowy, C. Fraser, T.R. (1970) Mortality in acromegaly. Quarterly Journal of Medicine, 39, 1 16.
2. Dekkers, O.M., Biermasz, N.R., Pereira, A.M., Romijn, J.A. Vandenbroucke, J.P. (2007) Mortality in acromegaly: a meta-analysis. Journal of Clinical Endocrinology and Metabolism, 93, 61 67.
3. Biermasz, N.R., Romijn, J.A., Pereira, A.M. Roelfsema, F. (2005) Current pharmacotherapy for acromegaly: a review. Expert Opinions in Pharmacotheraphy, 6, 2393 2405.
4. Feenstra, J., de Herder, W.W., ten Have, S.M., van den Beld, A.W., Feelders, R.A., Janssen, J.A. van der Lely, A.J. (2005) Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly. Lancet, 365, 1644 1646.
5. Melmed, S. (2006) Medical progress: acromegaly. New England Journal of Medicine, 355, 2558 2573.
6. van der Lely, A.J., Hutson, R.K., Trainer, P.J., Besser, G.M., Barkan, A.L., Katznelson, L., Klibanski, A., Herman-Bonert, V., Melmed, S., Vance, M.L., Freda, P.U., Stewart, P.M., Friend, K.E., Clemmons, D.R., Johannsson, G., Stavrou, S., Cook, D.M., Phillips, L.S., Strasburger, C.J., Hackett, S., Zib, K.A., Davis, R.J., Scarlett, J.A. Thorner, M.O. (2001) Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet, 358, 1754 1759.
7. Hua, S.C., Yan, Y.H. Chang, T.C. (2006) Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly. European Journal of Endocrinology, 155, 831 837.
8. Kauppinen-Makelin, R., Sane, T., Sintonen, H., Markkanen, H., Valimaki, M.J., Loyttyniemi, E., Niskanen, L., Reunanen, A. Stenman, U.H. (2006) Quality of life in treated patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 91, 3891 3896.
9. Trepp, R., Everts, R., Stettler, C., Fischli, S., Allemann, S., Webb, S.M. Christ, E.R. (2005) Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL). Clinical Endocrinology, 63, 103 110.
10. Webb, S.M., Badia, X. Surinach, N.L. (2006) Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. European Journal of Endocrinology, 155, 269 277.
11. Rowles, S.V., Prieto, L., Badia, X., Shalet, S.M., Webb, S.M. Trainer, P.J. (2005) Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. Journal of Clinical Endocrinology and Metabolism, 90, 3337 3341.
12. Biermasz, N.R., van Thiel, S.W., Pereira, A.M., Hoftijzer, H.C., van Hemert, A.M., Smit, J.W., Romijn, J.A. Roelfsema, F. (2004) Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. Journal of Clinical Endocrinology and Metabolism, 89, 5369 5376.
13. Paisley, A.N., Rowles, S.V., Roberts, M.E., Webb, S.M., Badia, X., Prieto, L., Shalet, S.M. Trainer, P.J. (2007) Treatment of acromegaly improves quality of life, measured by AcroQol. Clinical Endocrinology, 67, 358 362.
14. Zigmond, A.S. Snaith, R.P. (1983) The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361 370.
15. Smets, E.M., Garssen, B., Bonke, B. De Haes, J.C. (1995) The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. Journal of Psychosomatic Research, 39, 315 325.
16. Hunt, S.M., McKenna, S.P., McEwen, J., Backett, E.M., Williams, J. Papp, E. (1980) A quantitative approach to perceived health status: a validation study. Journal of Epidemiology and Community Health, 34, 281 286.
17. Hunt, S.M. McEwen, J. (1980) The development of a subjective health indicator. Sociology of Health and Illness, 2, 231 246.
18. Brazier, J.E., Harper, R., Jones, N.M., O'Cathain, A., Thomas, K.J., Usherwood, T. Westlake, L. (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care. British Medical Journal, 305, 160 164.
19. Ware, J.E. Jr. Sherbourne, C.D. (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30, 473 483.
20. Webb, S.M., Prieto, L., Badia, X., Albareda, M., Catala, M., Gaztambide, S., Lucas, T., Paramo, C., Pico, A., Lucas, A., Halperin, I., Obiols, G. Astorga, R. (2002) Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clinical Endocrinology, 57, 251 258.
21. Biermasz, N.R., van Dulken, H. Roelfsema, F. (2000) Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 85, 2476 2482.
22. Janssen, Y.J., Frolich, M. Roelfsema, F. (1997) A low starting dose of genotropin in growth hormone-deficient adults. Journal of Clinical Endocrinology and Metabolism, 82, 129 135.
23. Cole, T.J. (1990) The LMS method for constructing normalized growth standards. European Journal of Clinical Nutrition, 44, 45 60.
24. Rikken, B., van Doorn, J., Ringeling, A., Van den Brande, J.L., Massa, G. Wit, J.M. (1998) Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency. Hormone Research, 50, 166 176.
25. Hopman, W.M., Berger, C., Joseph, L., Towheed, T., VandenKerkhof, E., Anastassiades, T., Adachi, J.D., Ioannidis, G., Brown, J.P., Hanley, D.A. Papadimitropoulos, E.A. (2006) The natural progression of health-related quality of life: results of a five-year prospective study of SF-36 scores in a normative population. Quality of Life Research, 15, 527 536.
26. van Aken, M.O., Pereira, A.M., Biermasz, N.R., van Thiel, S.W., Hoftijzer, H.C., Smit, J.W., Roelfsema, F., Lamberts, S.W. Romijn, J.A. (2005) Quality of life in patients after long-term biochemical cure of Cushing's disease. Journal of Clinical Endocrinology and Metabolism, 90, 3279 3286.
27. Spiegler, B.J., Bouffet, E., Greenberg, M.L., Rutka, J.T. Mabbott, D.J. (2004) Change in neurocognitive functioning after treatment with cranial radiation in childhood. Journal of Clinical Oncology, 22, 706 713.